Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus

Circulation Research

Volumn 98, Issue 7, 2006, Pages 962-969

  Wang, Ji Shi ^a   Singh, Harpreet ^a   Zhang, Frank ^a   Ishizuka, Tsuneo ^a   Deng, Huan ^a   Kemp, Rowena ^a   Wolin, Michael S ^a   Hintze, Thomas H ^a   Abraham, Nader G ^a   Nasjletti, Alberto ^a   Laniado Schwartzman, Michal ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

20 HETE; Arachidonic acid; eNOS; Nitric oxide; Superoxide anion

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 3 NITROTYROSINE; ACETYLCHOLINE; ADENOVIRUS VECTOR; CYTOCHROME P450 4A; CYTOCHROME P450 4A2; CYTOCHROME P450 INHIBITOR; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ICOSANOID; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; CYTOCHROME P 450 CYP4A2 (RAT); CYTOCHROME P-450 CYP4A2 (RAT); CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME MECHANISM; GENE OVEREXPRESSION; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RENAL ARTERY; SMOOTH MUSCLE FIBER; SYNTHESIS; VASODILATATION; ADENOVIRUS; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; ENZYMOLOGY; GENE VECTOR; GENETICS; HEART MUSCLE; LEWIS RAT; METABOLISM; MOLECULAR CLONING; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

ADENOVIRIDAE; ANIMALS; BLOOD PRESSURE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; RATS, WISTAR;

EID: 33646163015     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000217283.98806.a6     Document Type: Article

References (56)

1. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
2. Zhang F, Wang MH, Krishna UM, Falck JR, Laniado-Schwartzman M, Nasjletti A. Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 2001;38:1311-1315.
3. Nakagawa K, Marji JS, Schwartzman ML, Waterman MR, Capdevila JH. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1055-R1062.
4. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989;243:388-390.
5. Imig JD, Zou AP, Ortiz-de-Montellano PR, Sui Z, Roman RJ. Cytochrome P450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am J Physiol. 1994;266:H1879-H1885.
6. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS, Roman RJ. Effect of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function. J Pharmacol Exp Ther. 1994;268:474-481.
7. Su P, Kaushal KM, Kroetz DL. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol. 1998;275:R426-R438.
8. Wang MH, Guan H, Nguyen X, Zand B, Nasjletti A, Laniado-Schwartzman M. Contribution of cytochrome P450 4A1 and 4A2 to vascular 20- hydroxyeicosatetraenoic acid synthesis in the rat kidney. Am J Physiol. 1998;276:F246-F253.
9. Muthalif MM, Benter IF, Khandekar Z, Gaber L, Estes A, Malik S, Parmentier JH, Manne V, Malik KU. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension. 2000;35:457-463.
10. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, Malik KU. Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension. 2000;36:604-609.
11. Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol. 2001;280:R255-R261.
12. + channel in renal arterioles. Am J Physiol. 1996;270:R228-R237.
13. Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RI. Inhibitors of cytochrome P450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res. 1991;68:1154-1163.
14. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res. 2000;87:60-65.
15. Kunert MP, Roman RJ, Alonso-Galicia M, Falck JR, Lombard JH. Cytochrome P-450 omega-hydroxylase: a potential O(2) sensor in rat arterioles and skeletal muscle cells. Am J Physiol Heart Circ Physiol. 2001;280:H1840-H1845.
16. Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD, Lombard JH, Lange AR, Roman RJ. Identification of a putative microvascular oxygen sensor. Circ Res. 1996;79:54-61.
17. Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol. 1997;273:R293-R300.
18. + channel activity and vascular tone in renal arterioles. Circ Res. 1998;83:1069-1079.
19. Frisbee JC, Falck JR, Lombard JH. Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension. Am J Physiol Heart Circ Physiol. 2000;278:H1517-H1526.
20. Randriamboavonjy V, Kiss L, Falck JR, Busse R, Fleming I. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res. 2005;65:487-494.
21. Wang MH, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, Laniado Schwartzman M. Cloning, sequencing and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch Biochem Biophys. 1996;336:240-250.
22. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther. 2000;7:1034-1038.
23. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734-3737.
24. Nguyen X, Wang MH, Reddy KM, Falck JR, Schwartzman ML. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol. 1999;276:R1691-R1700.
25. Wang JS, Zhang F, Jiang M, Wang MH, Zand BA, Abraham NG, Nasjletti A, Laniado-Schwartzman M. Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues. J Pharmacol Exp Ther. 2004;311:913-920.
26. Marji JS, Wang MH, Laniado-Schwartzman M. Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am J Physiol Renal Physiol. 2002;283:F60-F70.
27. Kaide J, Wang MH, Wang JS, Zhang F, Gopal VR, Falck JR, Nasjletti A, Laniado-Schwartzman M. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries. Am J Physiol Renal Physiol. 2003;284:F51-F56.
28. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminiski PM, Wolin MS, Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995;91:2982-2988.
29. Pucci ML, Tong X, Miller KB, Guan H, Nasjletti A. Calcium- and protein kinase C-dependent basal tone in the aorta of hypertensive rats. Hypertension. 1995;25:752-757.
30. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
31. Abraham NG, Jiang S, Yang L, Zand BA, Laniado Schwartzman M, Marji J, Drummond GS, Kappas A. Adenoviral vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent arachidonic acid epoxygenase activity. J Pharmacol Exp Therap. 2000;293:494-500.
32. Zhang F, Wang MH, Wang JS, Zand B, Gopal VR, Falck JR, Laniado-Schwartzman M, Nasjletti A. Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli. Am J Physiol Heart Circ Physiol. 2004;287:H1089-H1095.
33. Zhu D, Zhang C, Medhora M, Jacobs ER. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J Appl Physiol. 2002;93:330-337.
34. Yu M, McAndrew RP, Al-Saghir R, Maier KG, Medhora M, Roman RJ, Jacobs ER. Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries. J Appl Physiol. 2002;93:1391-1399.
35. Jiang M, Mezentsev A, Kemp R, Byun K, Falck JR, Miano JM, Nasjletti A, Abraham NG, Laniado-Schwartzman M. Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. Circ Res. 2004;94:167-174.
36. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene AS. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol. 2003;284:H1528-H1535.
37. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185.
38. Kerkhof CJ, Bakker EN, Sipkema P. Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries. Am J Physiol. 1999;277:H1546-H1552.
39. Obara K, Koide M, Nakayama K. 20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel. Br J Pharmacol. 2002;137:1362-1370.
40. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension. 2003;41:801-806.
41. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A. 2001;98:5211-5216.
42. Vapaatalo H, Mervaala E, Nurminen ML. Role of endothelium and nitric oxide in experimental hypertension. Physiol Res. 2000;49:1-10.
43. Cardillo C, Panza JA. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med. 1998;3:138-144.
44. Imig JD, Falck JR, Wei S, Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res. 2001;38:247-255.
45. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, Laniado-Schwartzman M. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors. J Pharmacol Exp Ther. 1998;284:966-973.
46. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A. 1998;95:9220-9225.
47. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:2153-2157.
48. Puntarulo S, Cederbaum AI. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic Biol Med. 1998;24:1324-1330.
49. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F. Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44-51.
50. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
51. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004;109:1795-1801.
52. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392:821-824.
53. Ward NC, Puddey IB, Hodgson JM, Beilin LJ, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic Biol Med. 2005;38:1032-1036.
54. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation. 2004;110:438-443.
55. Sun CW, Falck JR, Harder DR, Roman RJ. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension. 1999;33:414-418.
56. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR. Malik KU. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1998;95:12701-12706.